Falsified medicinal products is a serious and growing problem for patients, public health and other authorities. It is estimated that the rise in falsified drugs cause up to a million deaths a year. According to the World Health Organisation (WHO), one in 10 medicines sold worldwide is falsified amounting to $200 billion industry. In some areas of Africa, Asia, Latin America – more than 30% of medicines in circulation are falsified. Falsifying and distributing falsified drugs is a serious criminal offence.
In 2018 alone, Interpol in different field operations:
These stunning numbers do not include operations conducted by other international and local enforcement agencies making the amount of seized products to grow by more millions.
Pharmaceutical Security Institute data indicates that in 2018:
Falsifiers are well-organised criminal groups.
They use latest technologies in falsifying and are able to adapt quickly to latest market trends and innovations. We believe in our fight against fakes and it requires sustained commitment not only from national governments and international organisations, but also from the pharmaceutical industry including manufacturers and distributors.
Strauts Pharmaceuticals carefully manages its supply chain to ensure its safety and compliance with the highest standards. Having set the health and life of the patient as our highest priority, we focus on the quality and originality of the medication.
Our Partner Assessment Standard is not limited to the license check only. We examine the potential supplier’s reputation, quality system, warehouse space and a number of other factors to be confident about the quality of the medicines purchased and delivered to you.
Each order is firstly shipped to our warehouse. Before further delivery our specially trained staff inspects each package by using the latest falsification detection technology.
Our experts regularly upgrade their knowledge and expertise in specialized international conferences and seminars on the latest trends and technologies in anti-falsification methods. This allows us to incorporate the most recent recommendations given by the leading industry experts into our procedures.
No drug wholesaler is protected from the risk of purchasing falsified medicines.
Regular update of knowledge, exchange of experience and communication with manufacturers, supervisors and international organisations along with the use of the latest technologies and meticulous product check procedures ensure to receive original and safe product. An effective fight against falsified medicines requires the involvement of a variety of stakeholders, therefore we work with relevant government agencies, wholesalers, distributors, manufacturers, non-profit organisations and law enforcement agencies.
Any incident of supply or offer of falsified products is and will be reported to competent authorities immediately.